Margaret Ayo Owegi

Margaret Ayo Owegi is an Assistant Professor of Neurology at the University of Massachusetts Chan Medical School and T.H. Chan School of Medicine. Her clinical expertise lies in neuromuscular disorders, particularly amyotrophic lateral sclerosis (ALS), myasthenia gravis, muscular dystrophy, myopathy, and peripheral neuropathy. She completed her DO at Kansas City University of Medicine and Biosciences, followed by neurology residency and neuromuscular fellowship training at Johns Hopkins Hospital.

• Education:
  • BS in Chemistry, Indiana State University
  • MS in Chemistry, Ball State University
  • DO, Kansas City University of Medicine and Biosciences

Dr. Owegi's research focuses on ALS clinical trials, biomarker pathways, and therapeutic interventions. Her work spans neurology, pharmacology, and regenerative medicine, with recent publications addressing drug trials like pridopidine and CNM-Au8. Earlier studies explored yeast ATPase biochemistry, reflecting her interdisciplinary background.

Selected publications (2025-2005) demonstrate expertise in ALS clinical trial design, familial neurogenetics, and neuroimaging diagnostics. Her contributions include collaborations with leading ALS researchers and institutions, emphasizing translational approaches.

Key affiliations include UMass Chan Medical School's Neurology Department and membership in multidisciplinary ALS research teams. She has coauthored over 15 studies on ALS pathophysiology, stem cell therapies, genetic deletions, and enzymatic mechanisms.